HLS Therapeutics Inc.
HLS Therapeutics Inc. (TSX: HLS) is trading at CA$4.02, about ₹273 at today's CAD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 2.03% today. Indian residents can buy HLS Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CA$3.94
Today's high
CA$4.04
52 week low
CA$0.00
52 week high
CA$5.77
HLS opened at CA$3.95, closed previously at CA$3.94, and has traded between CA$0.00 and CA$5.77 over the past 52 weeks.
About
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Key statistics
Avg. volume
54.31K
Market cap
CA$125.73M
P/E Ratio
-10.50
Price-to-sales ratio
1.55
Enterprise value
$115.43M
Free cash flow yield
20.31%
Debt-to-equity ratio
0.76
Return on equity
-14.43%
ROIC
-3.99%
Beta
0.83
Dividend yield
0.00%
Last dividend
CA$0.00
Financial overview
Revenue
$56.47M
Earnings per share
-$0.40
Free cash flow
$15.81M
Net profit margin
-15.20%
Gross margin
61.41%
EBITDA
$18.02M
Revenue growth
-0.26%
Similar securities
This is not an investment recommendation
How to buy HLS Therapeutics from India
Indian residents can buy HLS Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CAD.
Search for HLS Therapeutics and place an order
Find HLS Therapeutics by name or by its ticker, HLS, and choose an order type. HLS Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your HLS Therapeutics position in CAD and INR. HLS Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in HLS Therapeutics from India
Trading and taxes when buying HLS Therapeutics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneHLS Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy HLS Therapeutics stock?
Yes. HLS Therapeutics (HLS) has been listed on the Toronto Stock Exchange since 2018, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CAD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one HLS Therapeutics share cost in rupees?
One HLS Therapeutics share is CA$4.02 — about ₹273 at a CAD/INR rate of 68.03 on 25 Sep 2026. Both the HLS Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying HLS Therapeutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on HLS Therapeutics shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CAD/INR rate on the purchase and the sale date, so the rupee move counts alongside the HLS Therapeutics price. Paasa issues a capital-gains statement for your return.
Does HLS Therapeutics pay a dividend?
No. HLS Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade HLS Therapeutics from India?
The Toronto Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when Canada is on standard time. Orders can only execute during that window.
Do I have to declare HLS Therapeutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your HLS Therapeutics holding, its cost and its closing value.
How do I sell HLS Therapeutics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in CAD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on HLS Therapeutics?
Yes. HLS Therapeutics is priced in CAD, so your rupee outcome combines the CAD move with the CAD/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.